期刊的影响因子--文章列表

期刊文章列表
Yan Guo，Yuqing Cui，Yangyang Li，Xiaoying Jin，Dandan Wang，Mengxia Lei，Fengzhi Chen，Yali Liu，Jinwen Xu，Guanyu Yao，Guangchun Zeng，Xuesong Chen（Department of Breast Medical Oncology；Department of Pathology）.Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer[J].癌症通讯(英文),2023,第5期 Carlotta Caterina Damanti，Lavinia Ferrone，Enrico Gaffo，Anna Garbin，Anna Tosato，Giorgia Contarini，Ilaria Gallingani，Roberta Angioni，Barbara Molon，Giulia Borile，Elisa Carraro，Marta Pillon，Federico Scarmozzino，Angelo Paolo Dei Tos，Marco Pizzi，Francesco Ciscato，Andrea Rasola，Alessandra Biffi，Stefania Bortoluzzi，Federica Lovisa，Lara Mussolin（Maternal and Child Health Department Pediatric Hematology；Pediatric Research Institute“Cittàdella Speranza”；Department of Molecular Medicine；Department of Biomedical Sciences；General Pathology and Cytopathology Unit）.Plasma small-extracellular vesicles enriched in miR-122-5p promote disease aggressiveness in pediatric anaplastic large-cell lymphoma[J].癌症通讯(英文),2023,第5期 Ling Peng，Yawen Bin，Peng Ding，Lingjuan Chen，Hao Zeng，Zelong Xu，Liyan Ji，Xuan Gao，Pian Liu，Ye Wang，Sheng Zhang，Zhongxing Liao，Xuefeng Xia，Ruiguang Zhang，Fan Tong，Xiaorong Dong（Cancer Center；Geneplus-Beijing；State Key Laboratory of Microbial Resources；GenePlus-Shenzhen Clinical Laboratory；Department of Radiation Oncology）.Integrated circulating tumor DNA and T cell repertoire predict radiotherapeutic response and outcome in non-small cell lung cancer patients with brain metastasis[J].癌症通讯(英文),2023,第5期 Annie W.Chan（Department of Radiation Oncology）.Knowing nodal Rouviére：the power of human intelligence in toxicity reduction[J].癌症通讯(英文),2023,第5期 Chaofan Liu，Xi Wang，Wan Qin，Jingyao Tu，Chunya Li，Weiheng Zhao，Li Ma，Bo Liu，Hong Qiu，Xianglin Yuan（Department of Oncology）.Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer[J].癌症通讯(英文),2023,第4期 Daojia Miao，QiWang，Jian Shi，Qingyang Lv，Diaoyi Tan，Chuanyi Zhao，Zhiyong Xiong，Xiaoping Zhang（Department of Urology；Institute of Urology）.N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis-regulated Hippo pathway[J].癌症通讯(英文),2023,第4期 Hiroyuki Suzuki，Hideki Iwamoto，Takahiro Seki，Toru Nakamura，Atsutaka Masuda，Takahiko Sakaue，Toshimitsu Tanaka，Yasuko Imamura，Takashi Niizeki，Masahito Nakano，Shigeo Shimose，Tomotake Shirono，Yu Noda，Naoki Kamachi，Miwa Sakai，Kazutoyo Morita，Masamichi Nakayama，Tomoharu Yoshizumi，Ryoko Kuromatsu，Hirohisa Yano，Yihai Cao，Hironori Koga，Takuji Torimura（Division of Gastroenterology；Liver Cancer Research Division；Iwamoto Internal Medicine Clinic；Department of Microbiology；Department of Surgery and Science；Department of Pathology）.Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors[J].癌症通讯(英文),2023,第4期 Tatiana Shaurova，Lingyue Yan，Yafei Su，Laurie James Rich，Vui King Vincent-Chong，Hannah Calkins，Saraswati Pokharel，Martin Petkovich，Mukund Seshadri，Yun Wu，Pamela Anne Hershberger（Department of Pharmacology and Therapeutics；Department of Biomedical Engineering；Cell Stress and Biophysical Oncology Graduate Program；Fujifilm-Visual Sonics Corporation；Department of Oral Oncology；Department of Pathology；Cancer Research Institute）.A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer[J].癌症通讯(英文),2023,第4期 Georgios Makris，Semih Kayhan，Marvin Kreuzer，Véronique Rüfenacht，Erica Faccin，Jarl Underhaug，Carmen Diez-Fernandez，Philip A.Knobel，Martin Poms，Nadine Gougeard，Vicente Rubio，Aurora Martinez，Martin Pruschy，Johannes Häberle（Division of Metabolism and Children’s Research Center；Center for Integrative Human Physiology；Department of Radiation Oncology；Department of Biomedicine；Department of Chemistry；NUVISAN GmbH；CDR Life Inc.；Division of Clinical Chemistry and Biochemistry；Instituto de Biomedicina de Valencia（IBV-CSIC））.Impact of small molecule-mediated inhibition of ammonia detoxification on lung malignancies and liver metabolism[J].癌症通讯(英文),2023,第4期 Yang Hao，Sen Ma，Zili Gu，Alireza Haghparast，Timo Schomann，Zhenfeng Yu，Yuanyuan He，Xiaoxv Dong，Luis J Cruz，Peter ten Dijke（Translational Nanobiomaterials and Imaging（TNI）Group；Department of Laboratory Animals；Department of Ophthalmology；Percuros B.V.；Immunology Section；School of Chinese Material Medica；Department of Cell and Chemical Biology and Oncode Institute）.Combination of photodynamic therapy and stimulator of interferon genes(STING)agonist inhibits colorectal tumor growth and recurrence[J].癌症通讯(英文),2023,第4期 Satoru Iwasa，Zi-Xian Wang，Kei Muro，Satoshi Morita，Young Suk Park，Dongsheng Zhang，Yasuhide Yamada，Junichi Sakamoto，TaeWon Kim（Department of Gastrointestinal Medical Oncology；Department of Medical Oncology；Department of Clinical Oncology；Department of Biomedical Statistics and Bioinformatics；Division of Hematology-Oncology；Comprehensive Cancer Center；Department of Medical Oncology；Tokai Central Hospital；Department of Oncology）.Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer：a post hoc analysis of the AXEPT study[J].癌症通讯(英文),2023,第4期 JungWoo Eun，Jung Hwan Yoon，Hye Ri Ahn，Seokhwi Kim，Young Bae Kim，Su Bin Lim，Won Park，TaeWook Kang，Geum Ok Baek，Moon Gyeong Yoon，Ju A Son，Ji HyangWeon，Soon Sun Kim，Hyo Jung Cho，Jae Youn Cheong（Department of Gastroenterology；Department of Pathology；Department of Biomedical Sciences；Department of Pathology；Department of Biochemistry&Molecular Biology；The Moagen）.Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib[J].癌症通讯(英文),2023,第4期 Peng Xia，Hao Zhang，Haofeng Lu，Kequan Xu，Xiang Jiang，Yuke Jiang，Xiangdong Gongye，Zhang Chen，Jie Liu，Xi Chen，Weijie Ma，Zhonglin Zhang，Yufeng Yuan（Department of Hepatobiliary&Pancreatic Surgery；Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary&Pancreatic Diseases of Hubei Province；Department of Hepatobiliary Surgery；Department of Clinical and Translational Research Center）.METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression[J].癌症通讯(英文),2023,第3期 Haiyan He，Liwei Xiao，Juhong Wang，Dong Guo，Zhimin Lu（Department of Pharmacy；Zhejiang Provincial Key Laboratory of Pancreatic Disease；Cancer Center；Department of Thoracic Surgery；State Key Laboratory of Molecular Oncology）.Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2[J].癌症通讯(英文),2023,第3期 Jayoung Kim，Hansong Lee，Chae Mi Hong，Ji Ho Nam，Hye Ju Yeo，Woo Hyun Cho，Hyung-Sik Kim，Changwan Hong，Yun Hak Kim，Dongjun Lee（Department of Convergence Medicine；Department of Biomedical Informatics；Department of Radiation Oncology；Division of Allergy；Department of Oral Pathology；Department of Anatomy）.Novel endogenous endoplasmic reticulum transmembrane protein SURF4 suppresses cell death by negatively regulating the STING-STAT6 axis inmyeloid leukemia[J].癌症通讯(英文),2023,第3期 Mingzhen Zhang，Ryan Maloney，Yonglan Liu，Hyunbum Jang，Ruth Nussinov（Computational Structural Biology Section；Cancer Innovation Laboratory；Department of Human Molecular Genetics and Biochemistry）.Activation mechanisms of clinically distinct B-Raf V600Eand V600K mutants[J].癌症通讯(英文),2023,第3期 Fuchen Liu，Xiaochen Feng，Jin Du，Minghao Ruan，Hui Liu（The Third Department of Hepatic Surgery）.Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection[J].癌症通讯(英文),2023,第3期 Yu-Fei Chen，Ying-ying Xu，Zhi-Ming Shao，Ke-Da Yu（Department of Breast Surgery；Shanghai Medical College；Department of Breast Surgery）.Resistance to antibody-drug conjugates in breast cancer：mechanisms and solutions[J].癌症通讯(英文),2023,第3期 Xiaoqiang Wang，Song Zhang，Di Jin，Jiamei Luo，Yumiao Shi，Yiqi Zhang，Lingling Wu，Yanling Song，Diansan Su，Zhiying Pan，Haige Chen，Ming Cao，Chaoyong Yang，Weifeng Yu，Jie Tian（Department of Anesthesiology；Department of Urology；Institute of Molecular Medicine；The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation）.μ-opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway：a comprehensive study including randomized controlled trial[J].癌症通讯(英文),2023,第3期 Julie Blanchi，Audrey Laroche-Clary，Francois Le Loarer，Benjamin Bonhomme，Antoine Italiano（SARCOTARGET team；Sarcoma Unit；Department of Pathology；Faculty of Medicine）.Prognostic impact of circulating tumor cells in patients with soft-tissue sarcomas：a prospective study[J].癌症通讯(英文),2023,第3期 Haiping Song，Hector Manuel Arredondo Carrera，Alexandria Sprules，Ying Ji，Tongsong Zhang，Jiepei He，Eleanor Lawrence，Alison Gartland，Jian Luo，Ning Wang（Department of Internal Medicine-Oncology；The Mellanby Centre for Musculoskeletal Research；Yangzhi Rehabilitation Hospital（Sunshine Rehabilitation Centre））.C-terminal variants of the P2X7 receptor are associated with prostate cancer progression and bonemetastasis–evidence from clinical and pre-clinical data[J].癌症通讯(英文),2023,第3期 Farhoodeh Ghaedrahmati，Nafiseh Esmaeil，Maryam Abbaspour（Department of Immunology；Research Institute for Primordial Prevention of Non-Communicable Disease；Department of Pharmaceutical Biotechnology）.Targeting immune checkpoints：how to use natural killer cells for fighting against solid tumors[J].癌症通讯(英文),2023,第2期 Zhiwei Chen，Peng Zhu，Zuojin Liu，Bin Zhu，Guobing Yin，Jia Ming，Rui Song，Qingbo Pan，Tong Li，Xingwei Jiang，Bing Wang，Shuaibin Liu，Hongxing Cai，Jingjie Wang，Yuling Han，Zijing Lin，Yang Hong，Min Chen，Mingli Peng，Lina Hu，Dachuan Cai，Hong Ren（Department of Infectious Diseases；Department of Gastrointestinal Surgery；Department of Hepatobiliary Surgery；Department of Thoracic and Cardiovascular Surgery；Department of Breast and Thyroid Surgery；Department of Gynaecology and Obstetrics）.Weakened humoral immune responses of inactivated SARS-CoV-2 vaccines in patients with solid tumors[J].癌症通讯(英文),2023,第2期 Fei Liu，ZixianWang，Xiaofan Li，Zhen Zhang，Yue Yang，Junquan Chen，Dinghua Chen，Lingling Wu，Xiangyu Liu，Sujun Han，Fangming Wang，Wasilijiang Wahafu，Yibo Gao，Shancheng Ren，Nianzeng Xing，Guangyan Cai，Xiangmei Chen（Department of Urology；Laboratory of Translational Medicine；Department of Thoracic Surgery；Department of Medical Oncology；Department of Nephrology；Department of Plastic Surgery；State Key Laboratory of Molecular Oncology；Central Laboratory；Department of Urology）.Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors[J].癌症通讯(英文),2023,第2期 Xi Zhan，RuiWu，Xue-Hua Kong，Yan You，Kun He，Xiao-Yu Sun，Yong Huang，Wei-Xian Chen，Liang Duan（Department of Laboratory Medicine；Department of Laboratory Medicine；Key Laboratory of Laboratory Medical Diagnostics；Department of Pathology；Department of Hepatobiliary Surgery）.Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma[J].癌症通讯(英文),2023,第2期 Qing Lin，Shangyou Zheng，Xianjun Yu，Meifu Chen，Yu Zhou，Quanbo Zhou，Chonghui Hu，Jing Gu，Zhongdong Xu，LinWang，Yimin Liu，Qingyu Liu，MinWang，Guolin Li，He Cheng，Dongkai Zhou，Guodong Liu，Zhiqiang Fu，Yu Long，Yixiong Li，Weilin Wang，Renyi Qin，Zhihua Li，Rufu Chen（Department of Pancreas Center；Department of Pancreatobiliary Surgery；Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Medical Research Center；Department of Pancreatic Surgery；Hunan Research Center of Biliary Disease/Department of Hepatobiliary Surgery；Department of Medical Statistics；Department of Anesthesiology；Department of Pathology；Department of Oncology；Department of Radiology；Department of Biliary-Pancreatic Surgery；Department of Hepatobiliary；Hepatobiliary and Pancreatic Interventional Treatment Center；Department of General Surgery；Department of Hepatobiliary and Pancreatic Surgery；Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province）.Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer：a multicenter randomized controlled trial[J].癌症通讯(英文),2023,第2期 Rui Liu，Panpan Liu，Huichang Bi，Jianhua Ling，Huiqin Zhang，Mingquan Zhang，Yumin Hu，Paul J Chiao，Peng Huang，Jinyun Liu（Sun Yat-sen University Cancer Center；School of Materials Science and Engineering；School of Pharmaceutical Sciences；Department of Molecular and Cellular Oncology；Metabolic Research Platform）.Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization[J].癌症通讯(英文),2023,第2期 Dongmei Mai，Ying Ye，Lisha Zhuang，Jian Zheng，Dongxin Lin（Department of Experimental Research；Department of Etiology and Carcinogenesis）.Detection of piRNA-54265 in human serum：evidence and significance[J].癌症通讯(英文),2023,第2期 Yuanyuan Zhao，Bing Zhao，Gang Chen，Yinlan Chen，Zijun Liao，Haiming Zhang，Weineng Feng，Yinyin Li，Heng Weng，Weidong Li，Yuefen Zhou，Biyong Ren，Yanda Lu，Jianhua Chen，Zhenteng Liu，Zhenzhong Su，Wenliang Wang，Li Zhang（Department of Medical Oncology；Department of Day Ward；Department of Medical Oncology；Department of Medical Oncology；Department of Medical Oncology；Department of Medical Oncology；Department of Medical Oncology；Respiratory Medicine；Department of Medical Oncology；Department of Medical Oncology；Department of Medical Oncology；Department of Medical Oncology；Department of Medical Oncology；Institute of Materia Medica）.Validation of different personalized risk models of chemotherapy-induced nausea and vomiting：results of a randomized,double-blind,phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin[J].癌症通讯(英文),2023,第2期 Limin Zou，Yueli Qi，Yongling Jiang，Ling Tang，Yu Du，Boyuan Zhao，Yanzhe Sun，Meiyi Xiang，Jun Ma，Zhimin Yang（Office of Clinical Evaluation 1；Office of Management and Communication；Harbin Institute of Hematology and Oncology）.Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China：from the perspective of clinical reviewers[J].癌症通讯(英文),2023,第2期首页上一页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表